Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Change in Account Payables (2018 - 2025)

Avai Bio's Change in Account Payables history spans 6 years, with the latest figure at $198294.0 for Q1 2024.

  • On a quarterly basis, Change in Account Payables rose 564.39% to $198294.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $844903.0, a 1896.7% increase, with the full-year FY2025 number at -$196536.0, down 123.26% from a year prior.
  • Change in Account Payables hit $198294.0 in Q1 2024 for Avai Bio, down from $335000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for AVAI hit a ceiling of $342709.0 in Q2 2023 and a floor of -$42700.0 in Q1 2023.
  • Historically, Change in Account Payables has averaged $101799.5 across 4 years, with a median of $44071.5 in 2022.
  • Biggest five-year swings in Change in Account Payables: soared 15159.26% in 2020 and later plummeted 894.25% in 2023.
  • Tracing AVAI's Change in Account Payables over 4 years: stood at $12198.0 in 2020, then soared by 58.06% to $19280.0 in 2022, then skyrocketed by 1637.55% to $335000.0 in 2023, then crashed by 40.81% to $198294.0 in 2024.
  • Business Quant data shows Change in Account Payables for AVAI at $198294.0 in Q1 2024, $335000.0 in Q4 2023, and -$31100.0 in Q3 2023.